RETRACTED ARTICLE: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial

Table 3 Changes of TBUT values between CN and DQ group

	0	4 weeks	12 weeks	Difference (0–4 weeks)^a	Difference (0–12 weeks)^a	P value (0–12 weeks)^b
CN	3.87 ± 1.32 (1.05~8.67)	4.64 ± 2.10 (1.01~13.17)	5.56 ± 2.50 (1.45~13.09)	0.77 ± 1.78 (−2.29~6.64)	1.69 ± 2.45 (−3.13~10.05)	< 0.0001
DQ	4.29 ± 1.85 (0.50~8.42)	4.46 ± 1.66 (0.73~8.67)	5.02 ± 1.85 (2.27~9.74)	0.17 ± 1.95 (−4.96~3.27)	0.73 ± 2.43 (−5.51~6.64)	0.0281
P value	0.3459	0.7668	0.3033	0.7350	0.1521

CN 0.05% cyclosporin nanoemusion (0.5 mg/mL), DQ 3% diquafosol sodium (30 mg/mL)
^aComparison between CN and DQ groups by Wilcoxon rank sum test
^bComparison among three groups by Kruskal-Wallis test

ISSN: 1471-2415